Brian Feroldi

Brian Feroldi


Brian Feroldi has been covering the healthcare and technology industries for the Motley Fool since 2015. Brian's investing goal is to find the highest quality companies that he can find, buy them, and then to sit back and let compounding work its magic. See all of his articles here and make sure you follow him on Twitter.

Recent articles

3 Medtech Earnings Winners

Guardant, Dexcom, and Insulet nailed their quarters and have massive room to grow in the long run, too.

Is Silk Road Medical a Buy?

The stroke prevention specialist is growing rapidly and has a huge opportunity ahead of it. Should investors get on board?

Why Avanos Medical Is Dropping Today

Shares slump after the company reports weak third-quarter results and cuts guidance. Here's what investors need to know.

Why Pinterest Is Tanking Today

Shares drop after the company reports mixed third-quarter results. Here's what investors need to know.

2 Hot Healthcare IPOs

These newly public companies have some big potential to change lives and reward investors.

Why AMAG Pharmaceuticals Is Tanking Today

Shares tumble after an FDA advisory committee recommends pulling one of the company's key drugs from the market. Here are the must-know details.